Interleukin-12-secreting human papillomavirus type 16-transformed cells provide a potent cancer vaccine that generates E7-directed immunity

International Journal of Cancer

Volumn 81, Issue 3, 1999, Pages 428-437

  Hallez, Sophie ^a   Detremmerie, Odile ^a   Giannouli, Christina ^a   Thielemans, Kris ^b   Gajewski, Thomas F ^c   Burny, Arsène ^a   Oberdan, Leo ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSFORMATION; CELLULAR IMMUNITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; IMMUNE RESPONSE; IMMUNIZATION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY; WART VIRUS;

EID: 0032916209     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19990505)81:3<428::aid-ijc17>3.0.co;2-#     Document Type: Article

References (33)

1. CAVALLO, F., GIOVARELLI, M., GULINO, A., VACCA, A., STOPPACCIARO, A., MODESTI, A. and FORNI, G., Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J. Immunol., 149, 3627-3635 (1992).
2. CAYEUX, S., BECK, C., AICHER, A., DÖRKEN, B. and BLANKENSTEIN, T., Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines. Europ. J. Immunol., 25, 2325-2331 (1995).
3. CAYEUX, S., BECK, C., DÖRKEN, B. and BLANKENSTEIN, T., Coexpression of interleukin-4 and B7.1 in murine tumor cells leads to improved tumor rejection and vaccine effect compared to single gene transfectants and a classical adjuvant. Hum. Gene Ther., 7, 525-529 (1996).
4. CHEN, P.W., GEER, D.C., PODACK, E.R. and KSANDER, B.R., Tumor cells transfected with B7-1 and interleukin-12 cDNA induce protective immunity. Ann. N. Y. Acad. Sci., 795, 325-327 (1996).
5. CHONG, H., TODRYK, S., HUTCHINSON, G., HART, I.R. and VILE, R.G., Tumour cell expression of B7 co-stimulatory molecules and interleukin-12 or granulocyte-macrophage colony-stimulating factor induces a local antitumour response and may generate systemic protective immunity. Gene Ther., 5, 223-232 (1998).
6. COLOMBO, M.P., VAGLIANI, M., SPREAFICO, F., PARENZA, M., CHIODONI, C., MELANI, C. and STOPPACCIARO, A., Amount of IL-12 available at the tumor site is critical for tumor regression. Cancer Res., 56, 2531-2534 (1996).
7. COUGHLIN, C.M., WYSOCKA, M., KURZAWA, H.L., LEE, W.M., TRINCHIERI, G. and ECK, S.L., B7-1 and interleukin 12 synergistically induce effective antitumor immunity. Cancer Res., 55, 4980-4987 (1995).
8. DE BRUUN, M.L. and 12 OTHERS, Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class 1-restricted protection to HPV16-induced tumor cells. Cancer Res., 58, 724-731 (1998).
9. FALLARINO, F., ASHIKARI, A., BOON, T. and GAJEWSKI, T.F., Antigen-specific regression of established tumors induced by active immunization with irradiated IL-12-but not B7-1-transfected tumor cells. Int. Immunol., 9, 1259-1269 (1997).
10. GAJEWSKI, T.F., FALLARINO, F., UYTHENHOVE, C. and BOON, T., Tumor rejection requires a CTLA-4 ligand provided by the host or expressed on the tumor. J. Immunol., 156, 2909-2917 (1996).
11. GORMAN, C.M., MOFFAT, L.F. and HOWARD, B.H., High-efficiency gene transfer into mammalian cells. In: D.M. Glover (ed.), DNA cloning. Vol. II: A practical approach, pp. 143-165, IRL Press, Oxford (1985).
12. HELLSTRÖM, K.E., HELLSTRÖM, I. and CHEN, L., Can co-stimulated tumor immunity be therapeutically efficacious? Immunol. Rev., 145, 123-145 (1995).
13. HIBMA, M.H., TOMMASINO, M., VAN NEST, G., ELY, S.J., CONTORNI, M. and RAPPUOLI, R.C.L.V., Immune responses to HPV16 E7. In: M.A. Stanley (ed.), Immunology of human papillomaviruses, pp. 291-297. Plenum Press, London (1994).
14. KAST, W.M., FELTKAMP, M.C., RESSING, M.E., VIERBOOM, M.P., BRANDT, M.P. and MELIEF, C.J., Cellular immunity against human papillomavirus associated cervical cancer. Semin. Virol., 7, 117-123 (1996).
15. LAMONT, A.G. and ADORINI, L., IL-12: a key cytokine in immune regulation. Immunol. Today, 17, 214-217 (1996).
16. LLN, K.Y., GUARNIERI, F.G., STAVELEY-O'CARROLL, K.F., LEVITSKY, H.I., AUGUST, J.T., PARDOLL, D.M. and WU, T.C., Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res., 56, 21-26 (1996).
17. MARTIN-FONTECHA, A., CAVALLO, F., BELLONE, M., HELTAI, S., IEZZ, G., TORNAGHI, P., NABAVI, N., FORNI, G., DELLABONA, P. and CASORATTI, G., Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic anti-tumor immunity against different mouse tumors. Europ. J. Immunol., 26, 1851-1859 (1996).
18. MARTINOTTI, A., STOPPACCIARO, A., VAGLIANI, M., MELANI, C., SPREAFICO, F., WYSOCKA, M., PARMIANI, G., TRINCHIERI, G. and COLOMBO, M.P., CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with IL12 genes. Eur. J. Immunol., 25, 137-146 (1995).
19. MCNEIL, C., HPV vaccine treatment trials proliferate, diversify [news]. J. nat. Cancer Inst., 89, 280-281 (1997).
20. MURAILLE, E., DEVOS, S., THIELEMANS, K., URBAIN, J., MOSER, M. and LEO, O., Costimulation regulates the kinetics of interleukin-2 response to bacterial superantigens. Immunology, 89, 245-249 (1996).
21. NANNI, P., ROSSI, I., DE GIOVANNI, C., LANDUZZI, L., NICOLETTI, G., STOPPACCIARO, A., PARENZA, M., COLOMBO, M.P. and LOLLINI, P.L., Interleukin 12 gene therapy of MHC-negative murine melanoma metastases. Cancer Res., 58, 1225-1230 (1998).
22. PIZZOFERRATO, E., CHU, N.R., HAWLEY, T.S., LIEU, F.H., BARBER, B.H., HAWLEY, R.G., WATTS, T.H. and BERINSTEIN, N.L., Enhanced immunogenicity of B cell lymphoma genetically engineered to express both B7-1 and interleukin-12. Hum. Gene Ther., 8, 2217-2228 (1997).
23. SEDMAN, S.A., BARBOSA, M.S., VASS, W.C., HUBBERT, N.L., HAAS, J.A., LOWY, D.R. and SCHILLER, J.T., The full-length E6 protein of human papillomavirus type 16 has transforming and transactivating activities and cooperates with E7 to immortalize keratinocytes in culture. J. Virol., 65, 4860-4866 (1991).
24. SIMONS, J.W. and 17 OTHERS, Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer. Cancer Res., 57, 1537-1546 (1997).
25. STERN, P.L., Immunity to human papillomavirus-associated cervical neoplasia. In: G.F. Vande Woude and G. Klein, Advances in cancer research, pp. 175-211, Academic Press, London (1996).
26. TAHARA, H., ZITVOGEL, L., STORKUS, W.J., ZEH, H.J.I., MCKINNEY, T.G., SCHREIBER, R.D., GUBLER, U., ROBBINS, P.D. and LOTZE, M.T., Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J. Immunol., 154, 6466-6474 (1995).
27. TINDLE, R.W., Human papillomaviruses vaccines for cervical cancer. Curr. Opin. Immunol., 8, 643-650 (1996).
28. ZITVOGEL, L. and LOTZE, M.T., Role of interleukin-12 (IL12) as an anti-tumor agent: experimental biology and clinical application. Res. Immunol., 146, 628-638 (1995).
29. ZITVOGEL, L., MAYORDOMO, J.I., TJANDRAWAN, T., DELEO, A.B., CLARKE, M.R., LOTZE, M.T. and STORKUS, W.J., Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells. B7 costimulation. T helper cell-1-associated cytokine. J. exp. Med., 183, 87-97 (1996a).
30. ZITVOGEL, L., ROBBINS, P.D., STORKUS, W.J., CLARKE, M.R., MAEURER, M.J., CAMPBELL, R.L., DAVIS, C.G., TAHARA, H., SCHREIBER, R.D. and LOTZE, M.T., Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors. Eur. J. Immunol. 26, 1335-1341 (1996b).
31. ZITVOGEL, L., TAHARA, H., ROBBINS, P.D., STORKUS, W.J., CLARKE, M.R., NALESNIK, M.A. and LOTZE, M.T., Cancer immunotherapy of established tumors with IL-12. J. Immunol., 155, 1393-1403 (1995).
32. ZOU, J.P., YAMAMOTO, N., FUJII, T., TAKENAKA, H., KOBAYASHI, M., HERRMANN, S.H., WOLF, S.F. FUJIWARA, H. and HAMAOKA, T., Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells. Int. Immunol., 7, 1135-1145 (1995).
33. ZUR HAUSEN, H., Papillomavirus infections - a major cause of human cancers. Biochim. Biophys. Acta. 1288, F55-F78 (1996).